Top 100 CEO Interviews
Issue No. 46 - April/May 2009
HPS takes treatment overseas
Following a 20% increase in turnover in the last
financial year, Australia’s largest hospital, aged care and correctional services pharmaceutical supplier, HPS Pharmacies, is eyeing overseas business opportunities. Managing Partner, Bruce Heal says although following a strategic plan for consolidation in the past year, HPS exceeded its budget with a turnover of $112 million. During the next 12 months, the firm’s target is $132 million and Bruce expects to exceed it.
The 2010 target of $150 million is now comfortably within sight.
“It has been an exciting year with substantial progress in our core markets of SA and Victoria and increasing opportunities in NSW and Queensland,” he says.
Much of the growth over the coming year will flow from winning the tender to supply pharmaceuticals to the 500-bed South Australian Calvary Hospital Group which includes Calvary, North Adelaide; Wakefield Street, City; College Grove, Collinswood and Central Districts, Elizabeth.
“We had been providing a pharmacy within Calvary but will now be expanding the service and relocating to the hospital foyer for the convenience of patients and staff,” Bruce says.
“We are also developing an on-site isolator to produce and distribute oncology products in a more timely way.
“This will link closely to the new oncology suite at Calvary and will improve the communication and liaison between specialists and pharmacists while trimming pharmaceutical costs.”
HPS now services a significant amount of the private hospital business in SA. It also holds 25% of the Victorian private hospital accounts, following tender negotiations to supply oncology and other pharmaceutical products to the 180-bed John Fawkner Private Hospital in Melbourne.
“We see future growth in Sydney and Brisbane and are actively pursuing tender opportunities in both the public and private hospital system and also in correctional services,” Bruce says.
...
